Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now

Page 3 of 12

10. AstraZeneca PLC (NASDAQ:AZN)

Number of Hedge Fund Holders: 55

AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company that explores, develops, manufactures, and commercializes prescription medicines. It supplies its products and services to specialty and primary care physicians. AstraZeneca PLC (NASDAQ:AZN) distributes its products and services through local representative offices and distributors.

On April 30, Analyst Sachin Jain from Bank of America Securities reiterated a Strong Buy rating on AstraZeneca PLC (NASDAQ:AZN), backed by its promising pipeline and oncology growth. The analyst said that the company’s oncology sector is supported by a new baseline for volume growth and that it is well-prepared to deal with potential tariff effects because of its strategic manufacturing locations.

The analyst further supports the bullish stance with AstraZeneca PLC’s (NASDAQ:AZN) promising pipeline, which is anticipated to significantly contribute to future sales growth. In addition, upcoming data releases from key trials such as SERENA-6 and AVANZAR are also expected to unlock significant sales opportunities because of their transformative potential.

Page 3 of 12